X @Bloomberg
Bloomberg·2025-07-22 13:22
US regulators rejected a skin cancer treatment from Replimune in another sign of the agency’s new leadership taking a hard line on drug approvals https://t.co/3CmRAIaoBn ...
US regulators rejected a skin cancer treatment from Replimune in another sign of the agency’s new leadership taking a hard line on drug approvals https://t.co/3CmRAIaoBn ...